Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 470 of 5804
-
New hope for CML patients: asciminib trial targets treatment failures
Disease control Recruiting nowThis is an open label, phase 2 study investigating asciminib in patients previously treated with one line of TKI therapy.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Shock therapy maintenance may keep schizophrenia at bay
Disease control Recruiting nowSchizophrenia is one of the most severe and costliest mental disorders in terms of human suffering and societal expenditure. About 15-30% of patients do not respond to all known antipsychotics, including clozapine, the current gold-standard in these cases. Hence, a recent Cochran…
Phase: NA • Sponsor: Central Institute of Mental Health, Mannheim • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New drug cocktail aims to fight kidney cancer when immunotherapy fails
Disease control Recruiting nowThe researchers are doing this study to find out whether the combination of abemaciclib and cabozantinib is a safe and effective treatment for people with metastatic clear cell renal cell carcinoma (ccRCC) and translocation-associated renal cell cancer (tRCC). The researchers wil…
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New therapy aims to calm trauma in parents of kids with cancer
Symptom relief Recruiting nowThe goal of this Phase III randomized controlled trial is to evaluate the effectiveness of a novel psychotherapeutic intervention called Emotion and Symptom-focused Engagement (EASE) in parents caring for a child or adolescent with cancer. The main question it aims to answer is: …
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Could a daily pill stop chronic migraines in teens?
Disease control Recruiting nowMigraine is a disease that most often causes moderate to severe headache on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to light and sound, or other symptoms. The goals of the study are to evaluate adve…
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New diabetes shot GZR18 takes on semaglutide in major trial
Disease control OngoingThe main purpose of this study is to investigate the Efficacy and Safety of GZR18 Injection in Chinese Subjects with Type 2 Diabetes Mellitus and Poor Blood Glucose Control by Metformin Monotherapy or in Combination with Sodium-dependent Glucose Transporter 2 (SGLT2) Inhibitors o…
Phase: PHASE3 • Sponsor: Gan & Lee Pharmaceuticals. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New drug SHR-1918 targets stubborn high cholesterol in rare disease
Disease control CompletedThis is a multicenter, randomized, double-blind, placebo-controlled phase III clinical study to assess the reduction of low-density lipoprotein cholesterol (LDL-C) by SHR-1918 in patients with homozygous familial hypercholesterolemia (HoFH).
Phase: PHASE3 • Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New pill shows promise for rare blood disorder in phase 3 trial
Disease control CompletedThe purpose of this study is to evaluate the efficacy and safety of HSK39297 tablets compared to eculizumab in Patients with PNH who Are Naive to Complement Inhibitor Therapy.
Phase: PHASE3 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Engineered immune cells take on HIV-Linked cancers in first human trial
Disease control Recruiting nowThis phase I trial evaluates the side effects and usefulness of axicabtagene clioleucel (a CAR-T therapy) and find out what effect, if any, it has on treating patients with HIV-associated aggressive B-cell non-Hodgkin lymphoma that has come back (relapsed) or not responded to tre…
Phase: PHASE1 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New hope for muscle stiffness: Once-Daily pill tested in myotonic dystrophy
Symptom relief Recruiting nowA Randomized, Double-blind, Placebo-Controlled, Multi-Center Study to Investigate the Efficacy and Safety of Once Daily Mexiletine PR During 26 Weeks of Treatment in Patients with Myotonic Dystrophy Type 1 and Type 2 (HERCULES study)
Phase: PHASE3 • Sponsor: Lupin Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
New pill targets HER2 cancers in promising trial
Disease control Recruiting nowResearchers are looking for a better way to treat people who have solid tumors with HER2-activating mutations. Before a treatment can be approved for people to take, researchers do clinical trials to better understand its safety and how it works. In this trial, the researchers w…
Phase: PHASE2 • Sponsor: Bayer • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Gut bacteria may hold key to reversing prostate cancer drug resistance
Disease control Recruiting nowTo determine if dexamethasone or dexamethasone plus metronidazole restore sensitivity to abiraterone for the treatment of metastatic prostate cancer.
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New drug LP352 aims to control seizures in severe epilepsy over the long term
Disease control ENROLLING_BY_INVITATIONThis (DEEp OLE Study) is a multicentre, open-label study to investigate the long-term safety, efficacy, tolerability, and pharmacokinetics (PK) of LP352 in the treatment of seizures in children and adults with DEE who completed Study LP352-301 or LP352-302. The study consists of …
Phase: PHASE3 • Sponsor: Longboard Pharmaceuticals • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Virus therapy takes on deadly brain cancer in early trial
Disease control ENROLLING_BY_INVITATIONClinical study of a novel oncolytic virus Ad-TD-nsIL12 in the treatment of primary high-grade glioma
Phase: PHASE1, PHASE2 • Sponsor: Xiaorong Wu • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can vitamin a derivative revive immune therapy for breast cancer?
Disease control Recruiting nowThis is a Phase II, open-label study evaluating the efficacy and safety of combined treatment (retinoic acid) with immune checkpoint inhibitor in HER2-negative breast cancer patients who progressed during previous immune checkpoint inhibitors.
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New meningitis vaccine trial aims to protect 240 volunteers
⭐️ VACCINE ⭐️ Recruiting nowAssessment of immunogenicity, reactogenicity and safety of GNG-DE in comparison with the reference drug
Phase: PHASE3 • Sponsor: NPO Petrovax • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:07 UTC
-
AI-Powered camera could spot cervical cancer without a lab
Diagnosis Recruiting nowThe purpose of this study is to validate Automated Visual Evaluation (AVE), specifically the CINFinder version developed by DL Analytics, a point-of-care screening and triage diagnostic tool for cervical cancer based on the assessment of digital images through artificial intellig…
Phase: NA • Sponsor: DL Analytics • Aim: Diagnosis
Last updated Jun 27, 2026 09:00 UTC
-
Robotic suit lets paralyzed individuals walk hands-free – trial underway
Symptom relief Recruiting nowThis study aims to demonstrate the safety and effectiveness of the personal exoskeleton in individuals with spinal cord injury (SCI).
Phase: NA • Sponsor: Wandercraft • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
New radiation approach aims to shorten treatment for cervical cancer
Disease control Recruiting nowThe standard treatment for locally advanced cervical cancer is well established as a combination of chemotherapy and radiation, typically over 25-28 daily fractions with the addition of a brachytherapy boost to the primary tumor. An important component to treatment efficacy is ov…
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Firefighters get cutting-edge cancer screening in new pilot study
Diagnosis Recruiting nowThe purpose of this study is to further understand the clinical impact and follow-up steps that may be required based on using whole-body Magnetic Resonance Imaging (MRI) or whole-body ultrasound and blood tests to detect multiple cancers in firefighters. This study involves an …
Phase: NA • Sponsor: Inova Health Care Services • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC